U.S. Professional Services Stock News

Oxford Industries (OXM) just turned in a messy Q3 2026, with revenue of about $307 million and a basic EPS of roughly -$4.28, while trailing twelve month figures show revenue of about $1.5 billion and basic EPS hovering around -$0.19 as the business works through a choppy earnings patch. The company has seen quarterly revenue move from roughly $308 million in Q3 2025 to $307 million in Q3 2026, alongside a swing in basic EPS from about -$0.25 to -$4.28, leaving investors focused on how much...

Magnite (MGNI) has quietly pushed higher this week, extending gains that now leave the stock up about 11% over the past week and 8% over the past month, even as its past 3 months remain weak. See our latest analysis for Magnite. That recent strength comes after a tougher stretch, with the 90 day share price return still negative. The latest move to around $16 suggests improving sentiment rather than a full blown trend reversal, even though the three year total shareholder return remains...

Sotera Health (SHC) just navigated a complicated one two punch as affiliates of Warburg Pincus and GTCR unloaded 30 million shares in a secondary offering while the company simultaneously delivered earnings that topped Wall Street expectations. See our latest analysis for Sotera Health. At around $16.90, Sotera Health’s solid quarterly beat and heavy secondary selling come after a strong run. Its year to date share price return of 24.08 percent and three year total shareholder return of 96.74...

Boise Cascade (BCC) just put a date on its next chapter, with longtime CEO Nate Jorgensen set to retire in March 2026 and current COO Jeff Strom tapped as his successor. See our latest analysis for Boise Cascade. The leadership transition headlines come at a tricky time, with a recent 1 month share price return of 9.52 percent contrasting with a much weaker year to date share price return of 34.95 percent and a still impressive 5 year total shareholder return of 106.25 percent. This suggests...

If you are wondering whether Rivian Automotive's recent momentum makes it a bargain or a bubble, you are not alone, and that is exactly what we are going to unpack here. The stock is up 32.1% year to date and 27.2% over the last year, even after a modest 0.2% dip in the past week and a 6.6% gain over the past month, signaling shifting market expectations around its long term prospects. Investors have been reacting to a steady drumbeat of news around Rivian's ramp up in production capacity...

Wondering if Markel Group at around $2,125 a share is still a smart buy, or if most of the upside has already been priced in? You are not alone; this stock has quietly become a favorite among long term compounders. The share price is up around 4% over the last week, 3.1% over the last month, and an impressive 23.8% year to date, adding to 22.0% over 1 year, 66.1% over 3 years, and 110.3% over 5 years. Those gains sit against a backdrop of Markel steadily expanding its specialty insurance...

If you are wondering whether Corning's blistering run has already priced in the upside, you are not alone; this is exactly the kind of stock where valuation really matters. The share price has jumped 12.7% over the last week and 6.4% over the past month, with year to date gains of 101.7% that build on a 1 year return of 101.5%, 3 year return of 203.5% and 5 year return of 198.2%. Those kinds of moves have been underpinned by growing optimism around Corning's role in enabling next generation...

In late 2025, Acadian Asset Management Inc. completed the redemption of all its outstanding US$275 million 4.800% Senior Notes due July 27, 2026, using a previously arranged US$200 million term loan facility and cash on hand. At the same time, its majority-owned subsidiary entered into new three-year term loan and revolving credit agreements maturing in 2028, reshaping the group’s funding mix and access to liquidity. Next, we’ll examine how this refinancing, particularly the shift from fixed...

Brown-Forman (BF.B) is wrestling with an unusual problem, a deep Canadian boycott of U.S. spirits that has driven local sales down about 62%, forcing management to guide for a modest full year net sales decline. See our latest analysis for Brown-Forman. Despite the Canada hit and softer quarterly earnings, Brown-Forman shares have shown a 30 day share price return of 11.0% and a 90 day share price return of 12.25%. However, the 1 year total shareholder return of negative 29.22% and 5 year...

If you are wondering whether Signet Jewelers is still a hidden gem or if most of the upside has already been priced in, this article will walk you through what the numbers are really saying about its value. The stock has been on a bit of a rollercoaster, up 9.0% over the last week and 18.7% year to date, even after a recent 10.2% pullback over the last month, building on an impressive 265.3% gain over five years. Behind those moves, investors have been reacting to Signet's strategic push...

Earlier this week, Barclays initiated coverage on Teladoc Health with an Equal-Weight rating, adding a fresh analyst viewpoint on the virtual care provider’s current positioning. This new coverage highlights how Teladoc’s business model, growth prospects, and risk profile are increasingly under the microscope of major Wall Street firms. We’ll now explore how Barclays’ decision to begin coverage may influence Teladoc Health’s existing investment narrative and perceived long-term...

If you are wondering whether Borr Drilling still offers value after its recent run, or if the easy money has already been made, you are in the right place. The stock has climbed about 13.7% over the last week and 34.3% in the past month, while still sitting on a 122.1% gain over five years. This naturally raises questions about the balance between potential upside and risk from here. Recent moves have been driven by improving sentiment around offshore drilling and tightening jack up rig...

Truist Securities just upgraded DLocal (NasdaqGS:DLO) to Buy after a stronger than expected third quarter, pointing to new CEO Pedro Arnt’s early turnaround moves and more comfortable take rate trends. See our latest analysis for DLocal. The upgrade comes after a choppy stretch for the stock, with a 30 day share price return of negative 3.65 percent, a much healthier year to date share price return of 19.78 percent, and a 25.36 percent one year total shareholder return. This suggests momentum...

FIGS (FIGS) just cleared a key hurdle for investors, topping expectations on both earnings and revenue in its latest quarter, while a fresh Strong Buy rating and upbeat growth catalysts pushed sentiment higher. See our latest analysis for FIGS. The upbeat quarter and Strong Buy call are landing on top of powerful momentum, with an eye catching 30 day share price return of 33.30 percent and year to date share price return of 99.83 percent. The 1 year total shareholder return of 88.62 percent...

New Oriental Education & Technology Group (NYSE:EDU) has just been dropped from the Hang Seng China Enterprises Index, a move that could reshape how index-tracking funds and institutional investors position around the stock. See our latest analysis for New Oriental Education & Technology Group. The index removal lands at a delicate moment, with New Oriental’s 7 day share price return of 5.01 percent standing against a year to date share price return of negative 12.82 percent. At the same...

Himax Technologies (NasdaqGS:HIMX) is back on traders radar after new momentum in its WiseEye AI and FrontLED micro display, as well as progress toward mass producing Co Packaged Optics for AI data centers. See our latest analysis for Himax Technologies. The recent WiseEye and CPO milestones seem to have flipped sentiment, with the share price now at $9.48 and a 26.74% year to date share price return contributing to a 47.10% one year total shareholder return. This suggests momentum is...

Recently, Barclays began covering Envista Holdings, assigning the dental products maker an “Overweight” rating that reflects the bank’s favorable view of the company’s prospects. This new attention from a major financial institution brings Envista more firmly onto institutional investors’ radar, potentially increasing liquidity and broadening its shareholder base. Now we’ll examine how Barclays’ positive initiation of coverage fits with Envista’s existing investment narrative and what it...

If you are wondering whether Surgery Partners is a quietly mispriced opportunity or a value trap in the making, you are not alone. That is exactly what we are going to unpack here. The stock is down 4.9% over the last week and 22.4% year to date, but a 5.0% gain over the past month hints that sentiment may be starting to shift after a long 5 year slide of 42.3%. Recent headlines have focused on Surgery Partners expanding its network of ambulatory surgery centers and deepening relationships...

Earlier this month, Deere & Company expanded its Board from 10 to 11 directors by appointing Cargill Chair and CEO Brian Sikes as an independent director and committee member, while also announcing the upcoming retirement of President, John Deere Financial and CIO Raj Kalathur in January 2026 and affirming a quarterly dividend of US$1.62 per share payable in February 2026. At the same time, President Donald Trump’s public pressure on farm‑equipment pricing and plans to ease environmental...

If you are wondering whether Unity Software is still a bargain after its big rebound, or if the easy money has already been made, this breakdown will help you think through whether the current price really makes sense. The stock has climbed 9.8% over the last week, 13.6% over the past month, and is now up 99.8% year to date. However, the 5 year return of -66.6% is a reminder of how quickly market sentiment around Unity can swing. Recent price action has come alongside ongoing investor...

Wondering if Globant is a beaten down tech name or a quiet value opportunity waiting to be rediscovered? This breakdown will help you decide whether the current price really makes sense. Despite a modest 7.9% rise over the last month, the stock is still down 67.7% year to date and 68.7% over the past year, which indicates that sentiment has been heavily reset even as some investors are starting to edge back in. Recent news has focused on Globant doubling down on digital transformation, AI...

Helios Technologies has announced that Billy Aldridge will become President of its Electronics Segment on January 4, 2026, after serving as Senior Vice President, Managing Director of the segment since March 31, 2025, and building a career across Enovation Controls, FW Murphy, and Brunswick’s MerCruiser/Mercury division. This appointment elevates a leader with deep electronics and OEM experience at a time when Helios is emphasizing customer engagement and growth in its Electronics...

Beam Therapeutics has released updated Phase 1/2 BEACON trial data for its investigational sickle cell therapy risto-cel, showing efficient cell collection, high base-editing levels, and sustained increases in protective hemoglobin F alongside reductions in harmful hemoglobin S in patients with severe vaso-occlusive crises. A key insight is that risto-cel’s manufacturing process appears both efficient and predictable, with most patients needing only a single stem cell collection cycle, which...

If you are wondering whether Amphenol is still a smart buy after its huge run, or if you are late to the party, this breakdown will help you assess whether the current price makes sense. The stock has paused recently, remaining flat over the last week and down about 3.6% over the past month. That follows a climb of roughly 101% year to date and 90.1% over the last year. These gains have been supported by steady demand for Amphenol's connectivity and sensor solutions across data centers,...